期刊文献+

(2S,4S)-1-(4-硝基苄氧羰基)-2-[(3-烯丙氧羰基)-苯基氨基甲酰基]-吡咯烷-4-基硫醇的合成工艺改进 被引量:3

Improvement on the synthesis of(2S,4S)-1-(4-nitrobenzy-loxycarbonyl)-2-[(3-allyloxycarbonyl)-benziaminocarbonyl] pyrrolidine-4-mercaptan
下载PDF
导出
摘要 采用价格低廉的反-4-羟基-L-脯氨酸为原料,通过7步反应,制备尔他培南的关键中间体———标题化合物,总收率37%。原料来源方便,成本低,而且减少了毒害作用,增加了安全性,适宜于工业化生产。 ( 2S, 4S )-1-( 4-nitrobenzyloxycarbonyl )-2-[ ( 3-ally- loxycarbonyl)-benziaminocarbonyl ] pyrrolidine-4-mereaptan was prepared by using the inexpensive trans-4-hydroxyl-L-proline as the original material via seven steps of reactions to give an overall yield of 37 %. This method is environmentally friendly and more suitable for commercialization.
出处 《化学试剂》 CAS CSCD 北大核心 2007年第2期124-126,共3页 Chemical Reagents
基金 上海市科学技术委员会重点科技攻关资助项目(044319221)
关键词 抗生素 碳青霉烯 尔他培南 中间体 合成 antibiotics carbapenem ertapenem intermediate synthesis
  • 相关文献

参考文献5

二级参考文献43

  • 1吴永乐.新的碳青霉烯类抗生素[J].国外医药(抗生素分册),1995,16(3):178-182. 被引量:8
  • 2[1]Livermore DM, Carter MW, Bagel S, et al. In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia[J]. Antimicrob Agents Chemother, 2001,45(6): 1860- 1867.
  • 3[2]Odenholt 1, Lowdin E, Cars O. In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against grarn-positive and gram-negative bacteria [J]. Antimicrob Agents Chemother, 1998, 42(9): 2365 - 2370.
  • 4[3]Hoellman DB, Kelly LM, Credito K, et al. In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds[J]. Antimicrob Agents Chemother, 2002, 46 ( 1 ): 220-224.
  • 5[4]Gill CJ, Jackson JJ, Gerckens LS, et al. In vivo activity and phar macokinetic of a novel long-acting carbapenem antibiotic, MK-826(L-749,345) [J]. Antimicrob Agents Chemother, 1998, 42 ( 8 ):1996-2001.
  • 6[5]Sundelof JG, Hajdu R, Gill CJ, et al. Pharmacokinetics of L-749345, a long-acting carbapenem antibiotic, in primates[J]. Antimicrob Agents Chemother, 1997, 41(8): 1743 - 1748.
  • 7[6]Ortiz-Ruiz G, Caballero-Lopez J, Friedland IR, et al. A study eval uating the efficacy, safety, and tolerability of ertapenem versus cef triaxone for the treatment of community-acquired pneumonia in adults[J]. Clin Infect Dis, 2002, 34(8): 1076 - 1083.
  • 8[7]Tomera KM, Burdmann EA, Reyna OG, et al. Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study [J]. Antimicrob Agents Chemother, 2002, 46 (9): 2895 - 2900.
  • 9[8]Jimenez-Cruz F, Jasovich A, Cajigas J, et al. A prospective, multi center, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults[J]. Urology, 2002, 60( 1 ): 16 -22.
  • 10[9]Graham DR, Lucasti C, Malafaia O, et al. Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study [J]. Clin InfectDis,2002,34(11):1460-1468.

共引文献33

同被引文献23

  • 1陈章景,施耀国.新型碳青霉烯类抗生素厄他培南[J].中国抗感染化疗杂志,2004,4(4):251-256. 被引量:12
  • 2仲兆金,武燕彬,刘浚.艾他培南关键中间体的合成[J].中国药物化学杂志,2006,16(2):82-84. 被引量:6
  • 3张义凤,陈昊,彭久合,高瑞昶,张广明.碳青霉烯类抗生素厄他培南的合成[J].中国药科大学学报,2007,38(4):305-310. 被引量:6
  • 4Nishino Y, Komurasaki T, Yuasa T, et al. Practical large- sacle synthesis of the a - aminomethylpyrrolidin - 4 - yl - thio - containing side chain of the novel carbapenem antibiotic coripenem[J]. Org Process Res Dev, 2003, 7(5): 649 -654.
  • 5Semple G, Ryder H, Rooker DP, et al. (3R) -N- (1 - (tert- Butyl- carbonylmethyl) - 2, 3 - dihydro - 2 - oxo - 5 - (2 - pyridyl) - 1H - 1,4 - benzodiazepine - 3 - yl ) - N - ( 3 - ( methylamino ) phenyl ) urea (YF476) : a potent and orally active gastrin/CCK-B antagonist[J].J Med Chem, 1997, 40(3): 331 - 341.
  • 6Mu F, Coifing SL, Riese II DJ, et al. Design, synthesis, and biological e- valuation of a series of lavendustin a analogues that inhibit EGFR and Syk tyrosine kinases, as well as tubulin polymerization[J]. J Med Chem, 2001,44 (3) : 441 - 452.
  • 7上海交通大学.尔他培南的中间体N-保护-(2S,4S)-2-[(3-羟基羰基)-苯基氨基甲酰基]-吡咯烷-4-基硫醇:中国,200510030663[P]2006-03-29.
  • 8Sunagawa M, Matsumura H, Inoue T, et al. A novelcarbapenem antibiotic, SM27338 structure activity relationships[J]. J Antibiot, 1990, 43(5): 519 -532.
  • 9Sorbera LA, Rabasseda X, Castaner J, et al. MK20826[J]. Drugs Future, 2000, 25(8): 795 - 802.
  • 10Sunagawa M, Matsumura H, Inoue T, et al. A novel carbapenem antibiotic, SM27338 structure activity relationships[J]. J Antibiot, 1990, 43 (5): 519 -532.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部